Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster

Lancet. 2021 Mar 6;397(10277):854-855. doi: 10.1016/S0140-6736(21)00528-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • ChAdOx1 nCoV-19
  • Humans
  • Immunization, Secondary
  • SARS-CoV-2
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines
  • ChAdOx1 nCoV-19